63996-36-1

Basic information

• Product Name: 2-(4-Bromophenyl)pyriding
• Synonyms: 2-(4-BROMOPHENYL)PYRIDINE;2-(4-Bromophenyl)pyriding;2-(4-BroMophenyl)pyridin;Pyridine, 2-(4-broMophenyl)- 2-(4-BroMophenyl)pyridine
• CAS NO: 63996-36-1
• Molecular Formula: C₁₁H₈BrN
• Molecular Weight: 234.09
• Product Categories: pharmacetical;Heterocycle-Pyridine series
• Mol File: 63996-36-1.mol
• Article Data: 80

Chemical Properties

• Melting Point: 61.0 to 65.0 °C
• Boiling Point: 322.3 °C at 760 mmHg
• Flash Point: 148.7 °C
• Appearance: /
• Density: 1.426 g/cm³
• Vapor Pressure: 0.000531mmHg at 25°C
• Refractive Index: 1.606
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Toluene
• PKA: 4.29±0.25(Predicted)
• CAS DataBase Reference: 2-(4-Bromophenyl)pyriding(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-Bromophenyl)pyriding(63996-36-1)
• EPA Substance Registry System: 2-(4-Bromophenyl)pyriding(63996-36-1)

Safety Data

• Hazardous Substances Data: 63996-36-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H8BrN/c12-10-6-4-9(5-7-10)11-3-1-2-8-13-11/h1-8H

Upstream product

• 110-86-1 pyridine 
• 35920-23-1 acetic acid-(4-bromo-N-nitroso-anilide) 
• 72437-42-4 [(4-bromophenyl)diazenyl](phenyl)methyl hydroperoxide 
• 109-04-6 2-bromo-pyridine 
• 589-87-7 1,4-bromoiodobenzene 
• 118722-54-6 allyldimethyl(2-pyridyl)silane 
• 622-88-8 4-bromophenylhydrazine hydrochloride 
• 1008-89-5 2-phenylpyridine 
• 106-37-6 1.4-dibromobenzene 
• 197958-29-5 pyridin-2-ylboronic acid 
• 98-98-6 2-Picolinic acid 
• 108-86-1 bromobenzene 
• 68716-49-4 p-bromophenylboronic acid pinacol ester 
• 99-90-1 para-bromoacetophenone 

Downstream Products

• 129013-83-8 3-(4-bromophenyl)pyridine 
• 934564-31-5 C₂₄H₁₇NO 
• 1310797-98-8 C₄H₉C₁₂NH₇C₆H₄C₅NH₄ 
• 1310797-91-1 C₄H₉C₁₂NH₇CCC₆H₄C₅NH₄ 
• 1271322-48-5 (5-bromo-2-(pyridin-2-yl)phenyl)(phenyl)methanone 
• 1498234-57-3 methyl 4-((5-bromo-2-(pyridin-2-yl)phenyl)(hydroxy)amino)benzoate 
• 1220633-35-1 2-(4-(2-phenylethynyl)phenyl)pyridine 
• 1565863-68-4 2-(4-bromo-2-chlorophenyl)pyridine 
• 1630983-12-8 2-(4-(difluoromethyl)phenyl)pyridine 

Relevant articles and documents

Redox-active ferrocene-containing iridium(III) complex for non-volatile flash memory

A new ferrocene-containing iridium(III) complex (complex 2) has been designed and synthesized. Its structure, photophysical property, electrochemistry and memory behaviors were well investigated. The memory device with a sandwich structure of ITO/complex 2/Al (D2) exhibited flash memory performance with a bistable conductive process, which showed a high ON/OFF current ratio of 103, long retention time of 103 s, and low threshold voltage of ?0.55 V. After 105 read cycles, no significant degradation was observed in the ON and OFF states at a read voltage of 1.0 V. The ferrocene group of complex 2 serves as the redox-active unit, and a redox memory mechanism is proposed to explain the conductive process based on the analysis of I–V, cyclic voltammetry and theoretical calculation data. Thus, the design of redox-active metal complex used for novel non-volatile memory device provided an alternative strategy for the further development of organic memory materials and devices.u202c

Dual-Emissive Cyclometalated Iridium(III) Polypyridine Complexes as Ratiometric Biological Probes and Organelle-Selective Bioimaging Reagents

In this Article, we present a series of cyclometalated iridium(III) polypyridine complexes of the formula [Ir(N^C)2(N^N)](PF6) that showed dual emission under ambient conditions. The structures of the cyclometalating and diimine liga

Solution processable phosphorescent dendrimers based on cyclic phosphazenes for use in organic light emitting diodes (OLEDs)

A novel solution processable phosphorescent dendrimer based on cyclic phosphazene (CP) cores has been prepared and used as emissive layers in simple OLED architectures, providing efficiencies of 24.0 cd A-1 and 16.7 lm W-1. The Royal Society of Chemistry.

Dianthracene compound containing pyridyl at tail end and application thereof

The invention provides dianthracene compounds shown in a general formula I in the specification. In the general formula I, L1 and L2 represent single bonds, substituted or unsubstituted heterocyclic aromatic groups of C2-C60 or substituted or unsubstituted hydrocarbon aromatic groups of C6-C60; L3 represents a substituted or unsubstituted heterocyclic aromatic group of C2-C60 or a substituted or unsubstituted hydrocarbon aromatic group of C6-C60; L1, L2 and L3 are shown in a formula in the specification at different time; R10, R18, R21 and R23-R28 represent hydrogen, halogen and substituted or unsubstituted alkyl or alkoxy of C1-C10. The compounds have good luminescence properties, high electron transport capacities and terrific solubility and can be used in luminescent materials, electron transport materials and hole-blocking materials in the electroluminescence field. The invention also provides an organic electroluminescence device at least comprising a pair of electrodes and organic luminescent media between the electrodes. The organic luminescent media at least comprise the dianthracene compounds.

Compound with AMPK agonistic activity and preparation and application of prodrug thereof

The invention relates to a compound with AMPK agonistic activity and a prodrug thereof, and as well as a preparation method and medical application of a prodrug thereof. The compound has the structure shown in the formula (I), and the prodrug of the compound has the structure shown in the formula (II), wherein each group and the substituent are as defined in the specification. The invention discloses a preparation method of the compound and application of the compound in prevention and treatment AMPK related diseases, and the AMPK related diseases include, but are not limited to, energy metabolism abnormality related diseases. Neurodegenerative diseases and inflammation-related diseases and the like.